Koyfin Home > Directory > Health Care > Adamas Pharma > EBIT

Adamas Pharma EBIT Chart (ADMS)

Adamas Pharma annual/quarterly EBIT from 2012 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Adamas Pharma EBIT for the quarter ending June 06, 2020 was $-7m a -179.16% increase of 13m year over year
  • Adamas Pharma EBIT for the last 12 months ending June 06, 2020 was $-62m a -51.17% increase of 32m year over year
  • Adamas Pharma Annual EBIT for 2019 was $-90m a -27.33% increase of 25m from 2018
  • Adamas Pharma Annual EBIT for 2018 was $-115m a 23.53% decrease of -27m from 2017
  • Adamas Pharma Annual EBIT for 2017 was $-88m a 30.67% decrease of -27m from 2016
Other Income Statement Metrics:
  • Adamas Pharma EBITDA for the quarter ending December 12, 2018 was $-25m a -22.88% increase of 6m year over year
  • Adamas Pharma Net Income for the quarter ending December 12, 2018 was $-29m a -21.08% increase of 6m year over year
  • Adamas Pharma Total Revenue for the quarter ending September 09, 2018 was $11m a 94.65% increase of 10m year over year
View Chart On Koyfin

Quarterly ADMS EBIT Data

06/2020$-7m
03/2020$-13m
12/2019$-21m
09/2019$-20m
06/2019$-22m
03/2019$-27m
12/2018$-25m
09/2018$-29m
06/2018$-30m
03/2018$-31m

Annual ADMS EBIT Data

2019$-90m
2018$-115m
2017$-88m
2016$-61m
2015$-57m
2014$19m
2013$57m
2012$20m
2011$-8m